See also this year's filing and all EDGAR filings for this company.
PDF Report 0001452011_2012_Tanke_Biosciences_Corp.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001452011, Tanke Biosciences Corp
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 838,089 |
| 1 | AssetsCurrent | 18,913,734 |
| 2 | PropertyPlantAndEquipment | 4,771,299 |
| 3 | remainder_Assets | 363,884 |
| 4 | LiabilitiesLongTerm | 628,365 |
| 5 | LiabilitiesCurrent | 3,545,981 |
| 6 | remainder_Liabilities | 4,858,357 |
| 7 | GeneralAndAdministrativeExpense | 4,486,490 |
| 8 | SellingAndMarketingExpense | 2,463,901 |
| 9 | remainder_Expenses | 19,654,058 |
| 10 | remainder_Revenues | 23,832,727 |
| 11 | remainder_NetIncome | -364,372 |
| 12 | remainder_ComprehensiveNetIncome | 56,629 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 24,887,006 |
| 1 | Liabilities | 9,032,703 |
| 2 | Expenses | 26,604,449 |
| 3 | Revenues | 23,832,727 |
| 4 | StockholdersEquity | 15,854,303 |
| 5 | NetIncome | -3,136,094 |
| 6 | ComprehensiveNetIncome | -3,079,465 |
| 7 | BaseVar | 42,388,943 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.286 |
| 9 | EconomicCapitalRatio | 1.56 |
Edgar->Model Mapping
Feature Distribution
